However, when classifying the lesions as either low or high positive for PD-L1 based on a CPS cutoff value of ≥ 20, in 24% of the cases, the PD-L1 expression in the primary tumor did not match that in the lymph node metastases (57). The gene discussed is CD274; the disease is neoplasm.